PE77999A1 - Metodo para administrar una haloterapia - Google Patents

Metodo para administrar una haloterapia

Info

Publication number
PE77999A1
PE77999A1 PE1998000325A PE00032598A PE77999A1 PE 77999 A1 PE77999 A1 PE 77999A1 PE 1998000325 A PE1998000325 A PE 1998000325A PE 00032598 A PE00032598 A PE 00032598A PE 77999 A1 PE77999 A1 PE 77999A1
Authority
PE
Peru
Prior art keywords
halotherapy
dose
dry powder
respiratory tract
high portion
Prior art date
Application number
PE1998000325A
Other languages
English (en)
Inventor
Valentin Antonovich Vinogradov
Robert Stanley Dirksing
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE77999A1 publication Critical patent/PE77999A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Abstract

QUE COMPRENDE: A) OPERAR UN SURTIDOR QUE CONTIENE CLORURO DE SODIO EN POLVO SECO, EL CUAL LIBERA UNA DOSIS DEL POLVO PARA INHALARLO CUANDO SE APUNTA HACIA DENTRO DE LA BOCA DEL USUARIO; Y B) INHALAR LA DOSIS QUE COMPRENDE APROXIMADAMENTE 3 mg DEL POLVO SECO, EL CUAL TIENE UN RANGO DE TAMANO DE PARTICULA DE 2 MICRONES A 50 MICRONES, APROXIMADAMENTE, QUE LE PERMITE ALCANZAR LA PORCION ALTA DEL TRACTO RESPIRATORIO BAJO SIN ENTRAR EN LOS PULMONES DEL USUARIO, PROPORCIONANDO DICHA DOSIS UNA CONCENTRACION, EN LA PORCION ALTA DEL TRACTO RESPIRATORIO BAJO, SUFICIENTE PARA ADMINISTRAR HALOTERAPIA EFECTIVA. DICHO CLORURO DE SODIO EN POLVO SECO POSEE EXCIPIENTES PARA PREVENIR SU AGLOMERACION, E INGREDIENTES PARA REALZAR LA HALOTERAPIA, LOS QUE SE SELECCIONAN DE: CLORURO DE POTASIO, ACIDO ASCORBICO, MENTOL, SABORES DE MENTA, SABORES CITRICOS, REFRESCANTES DEL ALIENTO Y COMBINACIONES DE ESTOS. EL PRESENTE METODO PROPORCIONA UNA HALOTERAPIA A LA PORCION ALTA DEL TRACTO RESPIRATORIO BAJO, PARA EL TRATAMIENTO SINTOMATICO DE LOS MALESTARES OCASIONADOS POR EL RESFRIO COMUN Y ALERGIAS; Y UNA HIGIENE ORAL Y RESPIRATORIA GENERAL
PE1998000325A 1997-04-29 1998-04-29 Metodo para administrar una haloterapia PE77999A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/841,132 US5881720A (en) 1997-04-29 1997-04-29 Method of delivering halotherapy

Publications (1)

Publication Number Publication Date
PE77999A1 true PE77999A1 (es) 1999-10-13

Family

ID=25284102

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000325A PE77999A1 (es) 1997-04-29 1998-04-29 Metodo para administrar una haloterapia

Country Status (13)

Country Link
US (1) US5881720A (es)
EP (1) EP1017440A1 (es)
JP (1) JP2001527442A (es)
KR (1) KR20010020346A (es)
CN (1) CN1253509A (es)
AU (1) AU7258598A (es)
CA (1) CA2288257A1 (es)
CO (1) CO4960640A1 (es)
HU (1) HUP0004053A2 (es)
NO (1) NO995251L (es)
PE (1) PE77999A1 (es)
TR (1) TR199902556T2 (es)
WO (1) WO1998048875A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6976957B1 (en) 1998-06-22 2005-12-20 Origin Medsystems, Inc. Cannula-based surgical instrument and method
US6651654B2 (en) * 1999-03-22 2003-11-25 Zenon A. Rogacki X-salizer an exerciser for the lungs
WO2001062264A2 (en) * 2000-02-23 2001-08-30 The Procter & Gamble Company Halotherapy method by inhalation of sodium chloride
DE60133723T2 (de) * 2000-02-28 2009-07-02 PharmaKodex Ltd., Chippenham Verabreichungssystemen für oral anzuwendende arzneimittel
US6644309B2 (en) 2001-01-12 2003-11-11 Becton, Dickinson And Company Medicament respiratory delivery device and method
US6722364B2 (en) 2001-01-12 2004-04-20 Becton, Dickinson And Company Medicament inhalation delivery devices and methods for using the same
US6443152B1 (en) * 2001-01-12 2002-09-03 Becton Dickinson And Company Medicament respiratory delivery device
EP1450885B1 (en) 2001-09-28 2015-04-22 Kurve Technology, Inc. Nasal nebulizer
US6941948B2 (en) 2002-03-07 2005-09-13 Vectura Drug Delivery Medicament storage and delivery devices
AU2003249623A1 (en) 2002-05-09 2003-12-12 Kurve Technology, Inc. Particle dispersion chamber for nasal nebulizer
HU223431B1 (hu) * 2002-08-05 2004-07-28 László Budai Inhaláló eszköz légúti panaszok enyhítésére
HUP0700007A2 (en) * 2007-01-08 2008-10-28 Asthma Rehabilitacios Ct Kft Device and process for producing of natrium chloride aerosol for the disorders of the respiratory system
IT1401071B1 (it) * 2010-08-02 2013-07-12 Tecno Sun S R L Dispositivo per l'erogazione di sale medicale micronizzato
AU2011308865B2 (en) 2010-09-29 2017-01-05 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
MX2015013845A (es) 2013-04-01 2016-05-09 Pulmatrix Inc Polvos secos de tiotropio.
DK177788B1 (en) * 2013-07-12 2014-07-07 Liita Holdings Ltd Inhaler
CN107280954A (zh) * 2016-04-12 2017-10-24 上海合微智能科技有限公司 智能控制的盐疗洗鼻器
RU2681895C1 (ru) * 2018-03-20 2019-03-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный медицинский университет имени академика Е.А. Вагнера" Министерства здравоохранения Российской Федерации Способ повышения эффективности функционирования сильвинитовых физиотерапевтических помещений
CN109011058A (zh) * 2018-08-08 2018-12-18 马必芳 岩盐精油吸入器及其制备方法与应用
WO2020102455A1 (en) * 2018-11-13 2020-05-22 Infinity Salt Air Machine, Llc Portable halotherapy device for aerosolizing salt
US11819515B1 (en) * 2019-04-24 2023-11-21 John J. Brier System and method of use for halotherapy sessions
WO2024046582A1 (en) * 2022-09-02 2024-03-07 Liita Care Aps Pharmaceutical dry powder composition and methods for treating respiratory tract infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
WO1990013327A1 (en) * 1989-04-28 1990-11-15 Riker Laboratories, Inc. Dry powder inhalation device
GB9104650D0 (en) * 1991-03-05 1991-04-17 Glaxo Group Ltd Medicaments
AU650953B2 (en) * 1991-03-21 1994-07-07 Novartis Ag Inhaler
US5681555A (en) * 1991-04-22 1997-10-28 Gleich; Gerald J. Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
EP0558879B1 (en) * 1992-03-04 1997-05-14 Astra Aktiebolag Disposable inhaler
US5215221A (en) * 1992-05-07 1993-06-01 The Procter & Gamble Company Disposable unit dose dispenser for powdered medicants
US5510339A (en) * 1993-02-02 1996-04-23 Mayo Foundation For Medical Education And Research Method for the treatment of bronchial asthma by administration of topical anesthetics
AUPM411494A0 (en) * 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
US5656256A (en) * 1994-12-14 1997-08-12 The University Of North Carolina At Chapel Hill Methods of treating lung disease by an aerosol containing benzamil or phenamil
US5676643A (en) * 1995-02-13 1997-10-14 The Procter & Gamble Company Dispenser for friably releasing dry particulate medicaments
US5747002A (en) * 1995-04-05 1998-05-05 Genentech, Inc. Preparation of sodium chloride aerosol formulations

Also Published As

Publication number Publication date
HUP0004053A2 (hu) 2001-08-28
WO1998048875A9 (en) 1999-03-25
AU7258598A (en) 1998-11-24
NO995251L (no) 1999-12-28
KR20010020346A (ko) 2001-03-15
NO995251D0 (no) 1999-10-27
CO4960640A1 (es) 2000-09-25
EP1017440A1 (en) 2000-07-12
CA2288257A1 (en) 1998-11-05
WO1998048875A1 (en) 1998-11-05
JP2001527442A (ja) 2001-12-25
US5881720A (en) 1999-03-16
CN1253509A (zh) 2000-05-17
TR199902556T2 (xx) 2000-01-21

Similar Documents

Publication Publication Date Title
PE77999A1 (es) Metodo para administrar una haloterapia
EP0448895B1 (en) Use of a non-alcoholic delivery system for active ingredients which are ingested orally
HUP0201877A2 (hu) Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák
IT1220979B (it) Capsule contenenti un allergene e procedimento per la loro preparazione
DE69532031D1 (de) Schilddrüsenhormone enthaltende mittel
ES2043268T3 (es) Dispositivo de distribucion para agentes terapeuticos que se administran por via oral.
EP0163723B1 (en) Ddavp antidiuretic and method therefor
EA200200126A1 (ru) Гидродинамически сбалансированная пероральная система доставки лекарства
IL108705A0 (en) Pharmaceutical compositions containing bisacodyl in dosage form
DK342989A (da) Betaendelseshaemmende middel
ES2175663T3 (es) Composiciones farmaceuticas solidas que contienen miltefosina para administracion oral en el tratamiento de la leshmaniasis.
Hardie The Evil Eye in Some Greek Villages of the Upper Haliakmon Valley in West Macedonia.
HUP0400127A2 (hu) Paracetamolt tartalmazó lenyelhető tabletta
US6362225B1 (en) Target therapies for treating common viral infections
Barach et al. Inhalation of Nebulized Promin in Experimental Tuberculosis: Sodium P, P'-Diaminodiphenylsulfone-N, N'-Didextrose Sulfonate
Kosman Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP)
JP2011111418A (ja) 口腔内局所投与に適したウイルス感染予防製剤
EP1017363A1 (en) Taste masking for unpalatable formulations
US20060287364A1 (en) Methods of prevention of infection with HIV/AIDS, venereal disease and influenza
JPS61280419A (ja) 治療用錠剤状製剤
GB950162A (en) Medicines for the treatment of hepatic disorders
JP2004315470A (ja) ヨウ化ナトリウム含有製剤
US3035972A (en) Preparation and method for obtaining relief from coughing
RU2002126216A (ru) Фармацевтическая композиция для лечения и профилактики фиброза и цирроза печени
Clyde et al. Therapeutic trials of chloroquine silicate in Tanganyika

Legal Events

Date Code Title Description
FX Voluntary withdrawal